There is also evidence of PIK3CA amplification and overexpression in different cancers, as well as numerous other oncogenic abnormalities, including frequent mutation, deletion and loss of expression of the tumour suppressor gene PTEN (Figure 1) [6, 7]. This evidence concerns the gene PTEN and cancer.